Stay updated on Nivolumab & Lenalidomide in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page.

Latest updates to the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Locations: Georgia and Ohio (Locations) and updated page to revision v3.3.3; removed HHS Vulnerability Disclosure and prior Georgia/Ohio Locations entries (revision v3.3.2).SummaryDifference0.3%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedA new revision labeled v3.3.2 has been added to the page's revision history, replacing the previous v3.2.0. This change is limited to version metadata and does not modify the study content or functionality.SummaryDifference0.1%

- Check52 days agoChange DetectedRemoved the bottom notice about government funding and NIH operating status. This change does not affect trial details, eligibility criteria, outcomes, or contact information.SummaryDifference0.4%

- Check66 days agoChange DetectedDifference0.4%

- Check95 days agoChange DetectedMajor: Update of operating status notice, new future dates, and new revision/version (v3.2.0); removal of prior dates and older revision (v3.1.0).SummaryDifference3%

- Check102 days agoChange Detected- The page version is updated to v3.1.0. - A specific term, “Diffuse large b-cell lymphoma,” has been removed from the content.SummaryDifference0.2%

Stay in the know with updates to Nivolumab & Lenalidomide in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page.